GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (OTCPK:BRAXF) » Definitions » Valuation Rank

BRAXF (Braxia Scientific) Valuation Rank


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Braxia Scientific Valuation Rank Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Braxia Scientific Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (OTCPK:BRAXF) » Definitions » Valuation Rank
Comparable Companies
THER LADX ISCO AXIM PXMD EMMA ARTH EVFM RMTG RGBP VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Website
https://www.braxiascientific.com
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.